Elsevier

Biochemical Pharmacology

Volume 51, Issue 1, 12 January 1996, Pages 39-45
Biochemical Pharmacology

Research paper
Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver

https://doi.org/10.1016/0006-2952(95)02113-2Get rights and content

Abstract

The stability of curcumin, as well as the interactions between curcumin and cytochrome P450s (P450s) and glutathione S-transferases (GSTs) in rat liver, were studied. Curcumin is relatively unstable in phosphate buffer at pH 7.4. The stability of curcumin was strongly improved by lowering the pH or by adding glutathione (GSH), N-acetyl l-cysteine (NAC), ascorbic acid, rat liver microsomes, or rat liver cytosol. Curcumin was found to be a potent inhibitor of rat liver P450 1A1/1 A2 measured as ethoxyresorufin deethylation (EROD) activity in α-naphthoflavone (βNF)-induced microsomes, a less potent inhibitor of P450 2B1/2B2, measured as pentoxyresorufin depentylation (PROD) activity in phenobarbital (PB)-induced microsomes and a weak inhibitor of P450 2E1, measured as p-nitrophenol (PNP) hydroxylation activity in pyrazole-induced microsomes. Ki values were 0.14 and 76.02 μM for the EROD- and PROD-activities, respectively, and 30 μM of curcumin inhibited only 9% of PNP-hydroxylation activity. In ethoxyresorufin deethylation (EROD) and pentoxyresorufin depentylation (PROD) experiments, curcumin showed a competitive type of inhibition. Curcumin was also a potent inhibitor of glutathione s-transferase (GST) activity in cytosol from liver of rats treated with phenobarbital (PB), β-naphthoflavone (βNF) and pyrazole (Pyr), when measured towards 1-chloro-2,4-dinitrobenzene (CDNB) as substrate. In liver cytosol from rats treated with phenobarbital (PB), curcumin inhibited GST activity in a mixed-type manner with a Ki of 5.75 μM and Ki of 12.5 μM. In liver cytosol from rats treated with pyrazole (Pyr) or β-naphthoflavone (βNF), curcumin demonstrated a competitive type of inhibition with Ki values of 1.79 μM and 2.29 μM, respectively. It is concluded that these strong inhibitory properties of curcumin towards P450s and GSTs, in addition to its well-known antioxidant activity, may help explain the previously observed anticarcinogenic, antimutagenic, and cytoprotective effects of this important natural compound and food constituent.

References (31)

  • ST Rao et al.

    Anti-inflammatory activity of curcumin analogues

    Indian J Med Res

    (1982)
  • RC Srimal et al.

    Pharmacology of diferuloyl methane (curcumin), a non steroidal anti-inflammatory agent

    J Pharm Pharmacal

    (1973)
  • HPT Ammon et al.

    Mechanism of anti-inflammatory actions of curcumin and boswellic acids

    J Ethnopharmacol

    (1993)
  • Aznam Nurfina

    The synthesis of some symmetrical curcumin derivatives and the study of their anti-inflammatory activities as well as structure-activity relationships

  • M Nagabhushan et al.

    Non-mutagenicity of curcumin and its anti-mutagenic action versus chili and capsaicin

    Nutr Cancer

    (1986)
  • Cited by (0)

    Visiting fellow, Laboratory of Pharmacology and Toxicology, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia.

    View full text